Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Cocokara Fine (3098 JP)
Watchlist
47
Analysis
Consumer Staples
•
Japan
cocokara fine Inc. is a holding company established through a merger of SEIJO Corporation and Segami Medics. The Company operates drug chain stores which sell medicines, health food, cosmetics, nursery items and daily necessity goods.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Cocokara Fine
•
05 Aug 2026 07:49
Primer: Cocokara Fine (3098 JP) - Aug 2026
On October 1, 2021, Cocokara Fine Inc. merged with Matsumotokiyoshi Holdings Co., Ltd. to form MatsukiyoCocokara & Co., creating the largest...
αSK Primers
104 Views
Share
bullish
•
Thematic (Sector/Industry)
•
30 Aug 2021 21:20
The Polarising Pandemic in Japanese Retail
A complete review of the Japanese retail sector in the last 18 months, format by format, category by category, providing key trends and winners &...
Michael Causton
Follow
522 Views
Share
bullish
•
Thematic (Sector/Industry)
•
18 Sep 2020 18:12
Japan Retail Review 2019-20 Part II: A Sector by Sector Review of Winners and Losers
At least until the Covid-19 crisis hit Japan in January, the majority of retailers were gearing up to announce yet another really good year of...
Michael Causton
Follow
601 Views
Share
bearish
•
Thematic (Sector/Industry)
•
14 May 2020 07:43
🇯🇵 JAPAN • Results & Revisions 13th May - Matsumotokiyoshi, Fuji Media, Seino
In the DETAIL below, we shall review the results, revisions and initial forecast announcements made by larger-cap companies yesterday:- The...
Campbell Gunn
Follow
509 Views
Share
bullish
•
Thematic (Sector/Industry)
•
13 Mar 2020 03:04
Japanese Drugstores: With Maturity Comes Marriage
The following is an in-depth review of the drugstore sector and the impact of the Cocokara Fine and Matsukiyo merger on other key drugstore stocks,...
Michael Causton
Follow
665 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x